Anti-Müllerian hormone (AMH) is a peptide belonging to the transforming growth factor beta
superfamily and acts exclusively through its receptor type 2 (AMHR2). From the 8th week of …

Objective To determine the relationship between high antimüllerian hormone (AMH) levels
and increased preterm delivery risk in populations of women with polycystic ovary syndrome …

In ovarian carcinoma, anti-Müllerian hormone (AMH) type II receptor (AMHRII) and the
AMH/AMHRII signaling pathway are potential therapeutic targets. Here, AMH dose …

Objective We aimed to identify the factors that influence serum anti-Müllerian hormone
(AMH) concentration measurements. Methods We collected serum samples between May …

Background Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related
deaths worldwide despite advances in cancer therapeutics. In several gynecological …

Simple Summary Endometrial cancer (EC) is the most common malignant neoplasm of the
female genitalia. Depending on the type and stage of EC, different classical treatment …

Background Reduced ovarian reserve is among the crucial long‐term side effects of using
chemotherapy agents in breast cancer, yielding early ovarian failure. On the other hand …

Anti-Müllerian hormone (AMH) is responsible for the Müllerian ducts' regression in male
fetuses. In cells of cancers with AMH receptors (AMHRII), AMH induces cell cycle arrest or …

Research question Is endometrial expression of anti-Müllerian hormone (AMH) and its
receptor II (AMH-R) altered in women with polycystic ovary syndrome (PCOS) and affected …

摘要目的研究高水平抗米勒管激素(AMH) 对多囊卵巢综合征(PCOS) 患者在冻融胚胎移植(FET)
周期妊娠结局的影响. 方法收集2019 年1 月至2021 年6 月于我院行FET 的PCOS …